176 related articles for article (PubMed ID: 12759492)
1. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
[TBL] [Abstract][Full Text] [Related]
2. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
Neurath AR; Strick N; Li YY; Jiang S
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients.
Spruth M; Stoiber H; Kacani L; Schönitzer D; Dierich MP
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):533-43. PubMed ID: 10221530
[TBL] [Abstract][Full Text] [Related]
4. The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanism.
Fraziano M; Montesano C; Lombardi VR; Marchione OP; Colizzi V
Clin Immunol Immunopathol; 1997 Aug; 84(2):202-7. PubMed ID: 9245553
[TBL] [Abstract][Full Text] [Related]
5. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
Willey S; Aasa-Chapman MM; O'Farrell S; Pellegrino P; Williams I; Weiss RA; Neil SJ
Retrovirology; 2011 Mar; 8():16. PubMed ID: 21401915
[TBL] [Abstract][Full Text] [Related]
6. Changes in HIV-specific antibody responses and neutralization titers in patients under ART.
Falkensammer B; Freissmuth D; Hübner L; Speth C; Dierich MP; Stoiber H
Front Biosci; 2007 Jan; 12():2148-58. PubMed ID: 17127452
[TBL] [Abstract][Full Text] [Related]
7. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
[TBL] [Abstract][Full Text] [Related]
8. A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.
Jia L; Xu Y; Zhang C; Wang Y; Chong H; Qiu S; Wang L; Zhong Y; Liu W; Sun Y; Qiao F; Tomlinson S; Song H; Zhou Y; He Y
Virol J; 2010 Jun; 7():142. PubMed ID: 20584336
[TBL] [Abstract][Full Text] [Related]
9. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
de Santis C; Lopalco L; Robbioni P; Longhi R; Rappocciolo G; Siccardi AG; Beretta A
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):157-62. PubMed ID: 7515259
[TBL] [Abstract][Full Text] [Related]
10. Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.
Scherl M; Posch U; Obermoser G; Ammann C; Sepp N; Ulmer H; Dierich MP; Stoiber H; Falkensammer B
Lupus; 2006; 15(12):865-72. PubMed ID: 17211992
[TBL] [Abstract][Full Text] [Related]
11. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of antibody reactivity against HIV-1 envelope and a peptide representing a conserved site on Gp41 in HIV-1-infected patients.
Mühlbacher M; Spruth M; Siegel F; Zangerle R; Dierich MP
Immunobiology; 1999 Jun; 200(2):295-305. PubMed ID: 10416136
[TBL] [Abstract][Full Text] [Related]
13. Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41.
Müller C; Kukel S; Schneweis KE; Bauer R
Clin Exp Immunol; 1994 Sep; 97(3):367-72. PubMed ID: 8082291
[TBL] [Abstract][Full Text] [Related]
14. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
16. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
17. Induction of complement-mediated lysis of HIV-1 by a combination of HIV-specific and HLA allotype-specific antibodies.
Hildgartner A; Wilflingseder D; Gassner C; Dierich MP; Stoiber H; Bánki Z
Immunol Lett; 2009 Sep; 126(1-2):85-90. PubMed ID: 19698750
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
20. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
